Skip to main content

Table 4 Economic outcomes: direct medical costs

From: Clinical, humanistic, and economic burden of severe hemophilia B in the United States: Results from the CHESS US and CHESS US+ population surveys

Mean (SD), unless noted

CHESS US

n = 44

Hemophilia consultation

$271 ($113)

Other consultation

$73 ($66)

Blood tests

$191 ($116)

Other tests

$87 ($268)

Ward inpatient

$2,194 ($7,845)

ICU

$4,123 ($14,284)

Factor IX

$611,971 ($497,281)

Total direct medical cost (N = 44)—excluding FIX

$2,885 ($7,857)

Total direct medical cost (N = 44)—including FIX

$614,886 ($498,839)

  1. Costs were calculated in 2019 USD based on Factor IX consumption reported by the physicians, using Factor IX unit costs from IBM® Micromedex® RED BOOK®